226
M.C. Vega et al. / European Journal of Medicinal Chemistry 58 (2012) 214e227
[8] A. Moloney, Trial renews interest in Chagas’ disease, Lancet 374 (2009) 1490.
[29] M.A. Ardakani, R.K. Smalley, R.H. Smith, 1H- and 2H-Indazoles by thermal and
photolytic decomposition of o-azidobenzoic acid and o-azidobenzaldehyde
derivatives, J. Chem. Soc. Perkin Trans. 1 (1983) 2501e2506.
[30] P. Bruneau, P.J. Taylor, A.J. Wilkinson, The tautomerism of indazolinone in
aqueous solution. A note on the ‘principle of vinylogy’, J. Chem. Soc. Perkin
Trans. 2 (1996) 2263e2269.
[9] U. S. National Institutes of Health, A Study of the Use of Oral Posaconazole
(POS) in the Treatment of Asymptomatic Chronic Chagas disease (P05267
(accessed 06.12); U. S. National Institutes of Health, Clinical Trial for the
Treatment of Chronic Chagas disease with Posaconazole and Benznidazole
06.12).
[31] N.J. Westwood, N.S.J. Isambert,
2005121096, 2005.
A Multicore Indazolinone Library, WO
[10] A. Montero-Torres, M.C. Vega, Y. Marrero-Ponce, M. Rolón, A. Gómez-Barrio,
J.A. Escario, V.J. Arán, A.R. Martínez-Fernández, A. Meneses-Marcel, A novel
non-stochastic quadratic fingerprints-based approach for the ‘in silico’
discovery of new antitrypanosomal compounds, Bioorg. Med. Chem. 13
(2005) 6264e6275.
[11] J.A. Castillo-Garit, M.C. Vega, M. Rolón, Y. Marrero-Ponce, A. Gómez-Barrio,
J.A. Escario, A. Álvarez Bello, A. Montero, F. Torrens, F. Pérez-Giménez,
V.J. Arán, C. Abad, Ligand-based discovery of novel trypanosomicidal drug-like
compounds: in silico identification and experimental support, Eur. J. Med.
Chem. 46 (2011) 3324e3330 (and references therein).
[12] Y. Marrero-Ponce, V. Romero-Zaldívar, TOMOCOMD-CARDD Software (2002).
TOMOCOMD (TOpological MOlecular COMputational Design-Computer Aided
“Rational” Drug Design) for Windows, version 1.0 is a preliminary experi-
mental version; in the future a professional version may be obtained upon
in Unit of Computer-Aided Molecular “Biosilico” Discovery and Bio-
informatic Research (CAMD-BIR Unit), Santa Clara, Villa Clara, Cuba.
[13] R. Chicharro, S. de Castro, J.L. Reino, V.J. Arán, Synthesis of tri- and tetracyclic
condensed quinoxalin-2-ones fused across the C-3eN-4 bond, Eur. J. Org.
Chem. (2003) 2314e2326 (and references therein).
[14] V.J. Arán, M. Flores, P. Muñoz, J.A. Páez, P. Sánchez-Verdú, M. Stud,
Analogues of cytostatic fused indazolinones: synthesis, conformational
analysis and cytostatic activity against HeLa cells of some 1-substituted
indazolols, 2-substituted indazolinones and related compounds, Liebigs
Ann. (1996) 683e691.
[15] V.J. Arán, M. Flores, P. Muñoz, J.R. Ruiz, P. Sánchez-Verdú, M. Stud, Cytostatic
activity against HeLa cells of a series of indazole and indole derivatives;
synthesis and evaluation of some analogues, Liebigs Ann. (1995) 817e824.
[16] V.J. Arán, C. Ochoa, L. Boiani, P. Buccino, H. Cerecetto, A. Gerpe, M. González,
D. Montero, J.J. Nogal, A. Gómez-Barrio, A. Azqueta, A. López de Ceráin,
O.E. Piro, E.E. Castellano, Synthesis and biological properties of new 5-
nitroindazole derivatives, Bioorg. Med. Chem. 13 (2005) 3197e3207.
[17] A. Montero-Torres, R.N. García-Sánchez, Y. Marrero-Ponce, Y. Machado-
Tugores, J.J. Nogal-Ruiz, A.R. Martínez-Fernández, V.J. Arán, C. Ochoa,
A. Meneses-Marcel, F. Torrens, Non-stochastic quadratic fingerprints and
LDA-based QSAR models in hit and lead generation through virtual
screening: theoretical and experimental assessment of a promising method
for the discovery of new antimalarial compounds, Eur. J. Med. Chem. 41
(2006) 483e493.
[18] M. Martins Alho, R.N. García-Sánchez, J.J. Nogal-Ruiz, J.A. Escario, A. Gómez-
Barrio, A.R. Martínez-Fernández, V.J. Arán, Synthesis and evaluation of 1,1’-
hydrocarbylenebis(indazol-3-ols) as potential antimalarial drugs, Chem-
MedChem 4 (2009) 78e87.
[19] O.M. Rivera-Borroto, Y. Marrero-Ponce, A. Meneses-Marcel, J.A. Escario,
A. Gómez Barrio, V.J. Arán, M.A. Martins Alho, D. Montero Pereira, J.J. Nogal,
F. Torrens, F. Ibarra-Velarde, Y. Vera Montenegro, A. Huesca-Guillén, N. Rivera,
C. Vogel, Discovery of novel trichomonacidals using LDA-driven QSAR models
and bond-based bilinear indices as molecular descriptors, QSAR Comb. Sci. 28
(2009) 9e26 (and references therein).
[32] W.E. Conrad, R. Fukazawa, M.J. Haddadin, M.J. Kurth, The Davis-Beirut reac-
tion: N1,N2-disubstituted-1H-indazolones via 1,6-electrophilic addition to
3-alkoxy-2H-indazoles, Org. Lett. 13 (2011) 3138e3141.
[33] M.J. Kurth, M.M. Olmstead, M.J. Haddadin, Claimed 2,1-benzisoxazoles are
indazalones [sic; actually, indazolones], J. Org. Chem. 70 (2005) 1060e1062.
[34] A.D. Mills, M.Z. Nazer, M.J. Haddadin, M.J. Kurth, N, N-Bond-forming hetero-
cyclization: synthesis of 3-alkoxy-2H-indazoles, J. Org. Chem. 71 (2006)
2687e2689.
[35] A.D. Mills, P. Maloney, E. Hassanein, M.J. Haddadin, M.J. Kurth, Synthesis of
a library of 2-alkyl-3-alkyloxy-2H-indazole-6-carboxamides, J. Comb. Chem. 9
(2007) 171e177.
[36] V.J. Arán, J.L. Asensio, J.R. Ruiz, M. Stud, Reactivity of 1,1-disubstituted indazol-
3-ylio oxides: synthesis of some substituted indazolols and indazolinones,
J. Chem. Soc. Perkin Trans. 1 (1993) 1119e1127.
[37] Yield of 3-isopropoxy-2-phenyl-2H-indazole 54 is unusually low. We have
observed that 2-phenylindazolinone 19 is rather unreactive toward isopropyl
bromide, and that compound 54 is not stable under the reaction conditions,
decomposing to a complex mixture from which only the starting indazolinone
19 could be identified (TLC); thus, compound 54 does not accumulate in the
reaction mixture. If the reaction is allowed to complete after ca. 9 days of
heating at 100 ꢀC, 90/10 A/B ratio included in Table 1 is observed, but at
shorter reaction times lower A/B ratios were found (e.g., 77/23 after 2.5 days
of heating, 65% yield of the mixture of compounds 36 and 54). Probably owing
to the same reasons, 3-propoxy derivative 53 does not accumulate during
alkylation of 2-phenylindazolinone 19 with propyl bromide and, in fact, it
could never be detected (NMR, TLC) in the reaction mixtures.
[38] L. Baiocchi, G. Picconi, On the isomerization of dialkyl indazolones to dihydro-
quinazolinones, Tetrahedron Lett. 27 (1986) 5255e5256.
[39] G.C. Hopkins, J.P. Jonak, H.J. Minnemeyer, H. Tieckelmann, Alkylations of
heterocyclic ambident anions. II. Alkylation of 2-pyridone salts, J. Org. Chem.
32 (1967) 4040e4044.
[40] D.L. Comins, G. Jianhua, N- vs. O-Alkylation in the Mitsunobu reaction of
2-pyridone, Tetrahedron Lett. 35 (1994) 2819e2822.
[41] A study of the effect of different experimental conditions during alkylation of
1-substituted indazol-3-ols, especially the nature of the employed bases, on
the observed ratios of N2- vs. O-substituted compounds is currently being
carried out. For example, in the case of the reaction of 1-methyl-5-
nitroindazol-3-ol 57 with methyl iodide in acetone at 100 ꢀC (autoclave),
the use of cesium, rubidium, potassium or sodium carbonate gives, respec-
tively, 23/77, 22/78, 29/71 and 46/54 A/C ratios, while the use of lithium
hydroxide (lithium carbonate does not work as a base in these reactions)
gives 84/16 A/C ratio.
[42] H. Liu, S.-B. Ko, H. Josien, D.P. Curran, Selective N-functionalization of
6-substituted 2-pyridones, Tetrahedron Lett. 36 (1995) 8917e8920.
[43] M. Sugahara, Y. Moritani, T. Kuroda, K. Kondo, H. Shimadzu, T. Ukita, An
efficient synthesis of the anti-asthmatic agent T-440: a selective N-alkylation
of 2-pyridone, Chem. Pharm. Bull. 48 (2000) 589e591.
[44] K.M. Tyler, D.M. Engman, The life cycle of Trypanosoma cruzi revisited, Int. J.
Parasitol. 31 (2001) 472e481.
[20] E. Lounkine, M. Wawer, A.M. Wassermann, J. Bajorath, SARANEA: a freely
available program to mine structure-activity and structure-selectivity rela-
tionship information in compound data sets, J. Chem. Inf. Model. 50 (2010)
68e78.
[21] L. Baiocchi, G. Corsi, G. Palazzo, Synthesis, properties, and reactions
of 1H-indazol-3-ols and 1,2-dihydro-3H-indazol-3-ones, Synthesis (1978)
633e648.
[22] V.J. Arán, E. Díez-Barra, A. de la Hoz, P. Sánchez-Verdú, Selective synthesis of
2-substituted indazolin-3-ones without N-1 protection, Heterocycles 45
(1997) 129e136.
[23] P. Bruneau, C. Delvare, M.P. Edwards, R.M. McMillan, Indazolinones, a new
series of redox-active 5-lipoxygenase inhibitors with built-in selectivity and
oral activity, J. Med. Chem. 34 (1991) 1028e1036.
[45] J. Bajorath, L. Peltason, M. Wawer, R. Guha, M.S. Lajiness, J.H. Van Drie,
Navigating structure-activity landscapes, Drug Discov. Today 14 (2009)
698e705.
[46] M. Wawer, E. Lounkine, A.M. Wassermann, J. Bajorath, Data structures and
computational tools for the extraction of SAR information from large
compound sets, Drug Discov. Today 15 (2010) 630e639.
[47] A.M. Wassermann, M. Wawer, J. Bajorath, Activity landscape representa-
tions for structure-activity relationship analysis, J. Med. Chem. 53 (2010)
8209e8223.
[48] M. Wawer, L. Peltason, N. Weskamp, A. Teckentrup, J. Bajorath, Struc-
ture-activity relationship anatomy by network-like similarity graphs and
local structure-activity relationship indices, J. Med. Chem. 51 (2008)
6075e6084.
[24] J. Schmutz, F. Hunziker, W. Michaelis, Über die Alkylierung von Indazolonen,
Helv. Chim. Acta 47 (1964) 1986e1996.
[25] S.D. Wyrick, P.J. Voorstad, G. Cocolas, I.H. Hall, Hypolipidemic activity of
phthalimide derivatives. 7. Structure-activity studies of indazolone analogues,
J. Med. Chem. 27 (1984) 768e772.
[26] J.A. Páez, N.E. Campillo, P. González, C. Pérez, V.J. Arán, M.I. Martín, R. Girón,
E.M. Sánchez, 3-Indazolyl Ether Family with Cannabinoid and/or Cholinergic
Properties, WO 2011039388, 2011.
[49] M.C. Vega, Trypanosoma cruzi: nuevos métodos colorimétricos de cribado y
alternativas terapéuticas, PhD thesis, Facultad de Farmacia, Universidad
Complutense, Madrid, Spain, 2005.
[50] J. Rodríguez, V.J. Arán, L. Boiani, C. Olea-Azar, M.L. Lavaggi, M. González,
H. Cerecetto, J.D. Maya, C. Carrasco-Pozo, H. Speisky Cosoy, New potent
5-nitroindazole derivatives as inhibitors of Trypanosoma cruzi growth:
synthesis, biological evaluation and mechanism of action studies, Bioorg. Med.
Chem. 17 (2009) 8186e8196 (and references therein).
[27] J. Kenner, E. Witham, The influence of nitro-groups on the reactivity of
substituents in the benzene nucleus. Part IV. The condensation of ethyl 3- and
5-nitro-2-chlorobenzoates with hydrazines, J. Chem. Soc. Trans. 119 (1921)
1053e1058.
[28] P. Bouchet, R. Lazaro, M. Benchidmi, J. Elguero, Photochimie d’hétérocycles
azotés-VI. Synthèse par voie photochimique d’amino et d’alkoxy indazoles,
Tetrahedron 36 (1980) 3523e3533.
[51] J. Xu, A. Hagler, Chemoinformatics and drug discovery, Molecules 7 (200)
566e600.
[52] J.W. Mc Farland, D.J. Gans, in: H. van de Waterbeemd (Ed.), Chemometric
Methods in Molecular Design, VCH Publishers, New York, 1995, pp. 295e307.
[53] S. Budavari, M.J. O’Neal, A. Smith, P.E. Heckelman, J.F. Kinneary (Eds.), The
Merck Index: An Encyclopedia of Chemicals, Drugs, and Biologicals, 12 ed.,
Merck & Co, Whitehouse Station, NJ, 1996.